IL-17 antagonistic antibodies

Details for Australian Patent Application No. 2005268857 (hide)

International Classifications

Event Publications

1 March 2007 PCT application entered the National Phase

PCT publication WO2006/013107 Priority application(s): WO2006/013107

28 January 2010 Application Accepted

Published as AU-B-2005268857

27 May 2010 Standard Patent Sealed

27 May 2010 Corrigenda

Applications Accepted - Name Index Under the name Novartis AG., Application No. 2005268857, under INID (71) correct the applicant to read Novartis AG

1 September 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 20 Jul 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

19 January 2012 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 20 Jul 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.